(Q30341146)

20 June 2017

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. (English)

1 reference

20 June 2017

0 references

11

R G Webster

1 reference

20 June 2017

8

J S Peiris

1 reference

20 June 2017

R J Webby

1

1 reference

20 June 2017

D R Perez

2

1 reference

20 June 2017

J S Coleman

3

1 reference

20 June 2017

Y Guan

4

1 reference

20 June 2017

J H Knight

5

1 reference

20 June 2017

E A Govorkova

6

1 reference

20 June 2017

L R McClain-Moss

7

1 reference

20 June 2017

J E Rehg

9

1 reference

20 June 2017

E I Tuomanen

10

1 reference

20 June 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

20 June 2017

5

1 reference

inferred from page(s)

published in

The Lancet

1 reference

20 June 2017

363

1 reference

20 June 2017

1099-1103

1 reference

20 June 2017

9415

1 reference

Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics

20 June 2017

1 reference

12 December 2020

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

12 December 2020

Development of a Vero cell-derived influenza whole virus vaccine.

1 reference

12 December 2020

Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses

1 reference

12 December 2020

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

1 reference

12 December 2020

Rescue of influenza A virus from recombinant DNA.

1 reference

12 December 2020

Future influenza vaccines and the use of genetic recombinants

1 reference

12 December 2020

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

1 reference

12 December 2020

Plasmid-only rescue of influenza A virus vaccine candidates.

1 reference

12 December 2020

Generation of influenza A viruses entirely from cloned cDNAs

1 reference

12 December 2020

Eight-plasmid system for rapid generation of influenza virus vaccines

1 reference

12 December 2020

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

12 December 2020

Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine

1 reference

12 December 2020

Characterization of avian H5N1 influenza viruses from poultry in Hong Kong

1 reference

12 December 2020

1 reference

12 December 2020

Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective.

1 reference

12 December 2020

Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain.

1 reference

12 December 2020

The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses

1 reference

12 December 2020

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

1 reference

12 December 2020

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

1 reference

12 December 2020

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics

1 reference

12 December 2020

Developing vaccines against pandemic influenza

1 reference

12 December 2020

Pandemic influenza and the global vaccine supply.

1 reference

12 December 2020

10.1016/S0140-6736(04)15892-3

Identifiers

DOI

1 reference

20 June 2017

1 reference